Full Press Release Details
Bacterin Announces 3Demin Cortical
BELGRADE, MT--(BUSINESS WIRE) - October 20, 2014 -- Bacterin
International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of bone graft material and coatings for medical applications,
today announced the launch of a demineralized allograft, 3Demin Cortical Fibers.
3Demin Cortical Fibers are the first product released
in Bacterin's latest 3Demin product family, and the second new product launched this year.
3Demin allografts may be used in a number of orthopedic and reconstructive applications, particularly spinal procedures.
The fibers are demineralized using Bacterin's proprietary processing technology and have excellent regenerative properties
for healing bone. The bone replacement market opportunity was estimated at $1.7 billion
The 3Demin Cortical Fibers have been launched to a limited
number of surgeons and health facilities for market feedback which has been encouraging. The 3Demin product family will
enhance Bacterin's existing biologic portfolio, and will provide an additional stream of revenue in the latter part of 2014
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE
MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. These products are used
in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot
and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division
develops, employs, and licenses coatings for various medical device applications. For further information, please visit www.bacterin.com.
Important Cautions Regarding Forward-looking
This news release contains certain disclosures that may be deemed
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant
risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer
to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates,"
"intends," "plans," "believes," "estimates," "projects," "forecasts,"
"strategy," "will," "goal," "target," "prospects," "potential," "optimistic,"
"confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical
fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties,
and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability
to meet its existing and anticipated contractual obligations, including financial covenant and other obligations contained in the
Company's secured lending facility; the Company's ability to manage cash flow and achieve profitability; the Company's
ability to remain listed on the NYSE MKT; the Company's ability to develop, market, sell and distribute desirable applications,
products and services and to protect its intellectual property; the ability of the Company's sales force to achieve expected results;
the ability of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as
and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees
with appropriate skills and expertise; the Company's ability to successfully conclude government investigations; the impact
of changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors;
and other factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form
10-Q under the heading "Risk Factors." The Company undertakes no obligation to release publicly any revisions to any
forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated
events, except as required by law.